Infectious Disease Control
Ascletis Announces Approval of Phase II Clinical Trial of ASC22 (Envafolimab) by China NMPA for Immune Restoration/Functional Cure of HIV-1 Infected Patients
HANGZHOU, China and SHAOXING, China, Nov. 10, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the approval of the Phase II clinical trial of ASC22 (Envafolimab) by China National Medical Products Administration (NMPA) for the proposed new indication of immune restoration/fu...
2021-11-10 08:30
2513
INOVIO Receives U.S. FDA Authorization to Proceed with INNOVATE Phase 3 Segment for its COVID-19 Vaccine Candidate, INO-4800, in the U.S.
FDA Lifts Partial Clinical Hold on INNOVATE Phase 3 Segment PLYMOUTH MEETING, Pa., Nov. 9, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from infectious diseases and treat cancer and HPV-a...
2021-11-09 21:00
2263
Recbio Announces New Study Showing Its COVID-19 Vaccine Induced High Levels of Neutralizing Antibodies against SARS-CoV-2 and Variants of Concern
TAIZHOU, China, Nov. 9, 2021 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. ("Recbio"), a biopharmaceutical company focusing on the research, development and commercialization of innovative vaccines that can address prevalent diseases with significant burden, today announced preclinical data...
2021-11-09 10:00
2699
Sustained Hepatitis B Surface Antigen Loss in Chronic Hepatitis B Patients with Subcutaneous PD-L1 Antibody ASC22 Treatment: Interim Results of Phase IIb Study
HANGZHOU, China and SHAOXING, China, Nov. 9, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) announces today that the interim results of 44 chronic hepatitis B (CHB) patients from a Phase IIb trial of ASC22 (Envafolimab), a subcutaneously administered PD-L1 antibody (ClinicalTrials.gov Ide...
2021-11-09 08:33
2861
At 2021 Grand Challenges Annual Meeting, Bill & Melinda Gates Foundation Announces Initiatives to Support Cutting-Edge Science in Low- and Middle-Income Countries and Help End the COVID Crisis
The foundation commits initial $50 million towards a new 10-year program and awards science leadership fellowships to 14 African scientists SEATTLE, Nov. 9, 2021 /PRNewswire/ -- Today at the 17th Grand Challenges Annual Meeting, the Bill & Melinda Gates Foundation announced an initial commitment...
2021-11-09 01:30
1710
Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO GAITHERSBURG, Md., Nov. 5, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infec...
2021-11-05 05:00
3068
Tetracore, Inc. Introduces First USDA-Licensed Real-Time PCR Test for the Detection of African Swine Fever Virus in Swine Whole Blood and Spleen Samples
ROCKVILLE, Md., Nov. 4, 2021 /PRNewswire/ -- Tetracore, Inc. (Tetracore) announced today the licensing of their VetAlert™ African Swine Fever Virus (ASFV) DNA Diagnostic Test Kit by the United States Department of Agriculture (USDA) Center for Veterinary Biologics (CVB). It is the first USDA l...
2021-11-04 20:02
2399
New progress of studies on Lianhua Qingwen's mechanism to fight against SARS-CoV-2
BEIJING, Nov. 4, 2021 /PRNewswire/ -- During the efforts to prevent and control the epidemic, "3 medicines and 3 prescriptions" are selected from traditional Chinese medicine inChina, including the representative medicine "Lianhua Qingwen ", produced by Yiling pharmaceutical, which has been widely...
2021-11-04 12:56
2323
Sensational artemisinin-piperaquine for treatment of COVID-19 in prospect
GUANGZHOU, China, Nov. 3, 2021 /PRNewswire/ -- Artequick artemisinin and piperaquine tablets have once again become buzzwords across the globe, as most recently, their effectiveness in treating COVID-19 was hotly debated by live streamers on overseas social media and we media platforms. These dru...
2021-11-03 22:42
2003
Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
- Submission to New Zealand's Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities inNew Zealand - All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe GAITHERSBURG, Md., Nov. 3, 20...
2021-11-03 22:14
3010
Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021
DÜSSELDORF, Germany, Nov. 3, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) will exhibit its advanced COVID-19 testing products and solutions in Hall 3 Stand F 94 at MEDICA 2021, the world's leading trade fair for the medical sector, in Messe Düsseldor...
2021-11-03 15:00
1769
Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021
DÜSSELDORF, Germany, Nov. 3, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) will exhibit its advanced COVID-19 testing products and solutions in Hall 3 Stand F 94 at MEDICA 2021, the world's leading trade fair for the medical sector, in Messe Düsseldor...
2021-11-03 15:00
2824
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
GAITHERSBURG, Md. and PUNE, India, Nov. 1, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine ma...
2021-11-01 18:57
3350
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval inAustralia -- In addition to today's submission to the Therapeutic Goods Administration, the company recently filed for authorization with MHRA, with additional filings in...
2021-10-29 19:15
5843
Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity
SEOUL, South Korea, Oct. 29, 2021 /PRNewswire/ -- Hanmi Science doesn't just want the world to know they are committed to vaccine equity, they want to prove it. Mr. Lim, CEO of Hanmi Science, echoes the concerns of Mr.Bill Gates, co-founder of the Bill & Melinda Gates Foundation. As Mr. Gates sta...
2021-10-29 09:27
2226
Interim report for Q3 2021 : Bactiguard Holding AB (publ)
STOCKHOLM, Oct. 28, 2021 /PRNewswire/ -- Capital injection initiates a new phase of accelerated expansion Third quarter (July-September 2021) * Revenues amounted to SEK 45.2 (34.1) million, an increase of 32%. Adjusted for currency effects revenues increased by 36%. * EBITDA amounted to SEK ...
2021-10-28 15:23
1596
Launch of Seegene's STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing
* A true walk away 'sample to answer' molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories * Utilizes Seegene's patented, cutting-edge high multiplex real-time PCR technologies to provide 'Real' Ct values...
2021-10-27 23:40
1960
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom
* Filing marks first protein-based COVID-19 vaccine submitted to MHRA for authorization * All modules required for regulatory review, including CMC data, are now complete * Submission based on Phase 3 data from ~45K patients demonstrating high efficacy and well-tolerated safety, including a...
2021-10-27 20:30
2476
Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines
TAIPEI, Oct. 27, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC)
2021-10-27 10:24
2782
Josip Heit comments on the current situation of dealing with the coronavirus
STOCKHOLM, Oct. 25, 2021 /PRNewswire/ -- GSB Gold Standard Pay KB Sweden: In
the intensive care units of the Federal Republic ofGermany, more people will
probably have to be treated with Covid-19 again in the near future; as has been
known for some time, this is due to the cold season.
2021-10-25 15:00
2197
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6801
